2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Mini-Oral Session

[MO43] Mini-Oral Session 43 Gastrointestinal Cancer 5(Miscellaneous)
【E】

Sat. Feb 19, 2022 3:50 PM - 4:40 PM Room 12 (Prince Hall 2, B2F, The Prince Kyoto Takaragaike)

Chair:Yasushi Tsuji(Department of Medical Oncology, Tonan Hospital),Ichinosuke Hyodo(Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center)

Ryuichi Morita1, Takeshi Ishikawa1,2, Kohei Asaeda1, Reo Kobayashi1, Hajime Miyazaki1, Tomoki Sakakida1, Toshifumi Doi1, Ken Inoue1, Osamu Dohi1, Akito Harusato1, Naohisa Yoshida1, Kazuhiko Uchiyama1, Tomohisa Takagi1, Hirotaka Konishi3, Atsushi Shiozaki3, Hitoshi Fujiwara3, Hideyuki Konishi1, Yoshito Itoh1 (1.Department of Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 2.Outpatient Oncology Unit, University Hospital, Kyoto Prefectural University of Medicine, 3.Divisions of Digestive Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine)

Keiji Sugiyama1, Kazuhiro Shiraishi1, Takuya Motohashi2, Shinpei Onoda2, Riko Nishibori1, Mariko Sato1, Kyoko Kato1, Hiroaki Uda3, Masaya Suenaga3, Masaaki Shimada4, Noboru Hirashima4, Masato Kataoka3, Chiyoe Kitagawa1 (1.Department of Medical Oncology, Nagoya Medical Center, 2.Department of Nutrition Service, Nagoya Medical Center, 3.Department of Surgery, Nagoya Medical Center, 4.Department of Gastroenterology, Nagoya Medical Center)

Keita Fukuyama1, Yukiko Mori3, Taiki Taniguchi2, Nomura Motoo3, Shigemi Matsumoto1, Manabu Muto3 (1.Department of Real World Data Research and Development, Graduate School of Medicine, Kyoto University, 2.Ministry of Health, Labour and Welfare, Health Policy Bureau, Regional Medical Care Planning Division, 3.Department of Clinical Oncology, Kyoto University Hospital)

Thierry Andre1, Dominique Berton2, Giuseppe Curigliano3, Susan L Ellard4, Jose Manuel Trigo Perez5, Hendrik-Tobias Arkenau6, Cyril Abdeddaim7, Wei Guo8, Ellie Im9, Naureen Starling10 (1.Sorbonne University and Saint-Antoine Hospital, 2.GINECO & Institut de Cancerologie de l'Ouest, Centre René Gauducheau, 3.Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, and University of Milano, 4.BC Cancer-Kelowna, 5.Medical Oncology Department, Hospital Ramón y Cajal, 6.Sarah Cannon Research Institute UK Limited, 7.Centre de Lutte Contre le Cancer-Centre Oscar Lambret, 8.START Madrid-FJD, Fundación Jiménez Diaz Hospital, 9.GlaxoSmithKline (GSK), 10.Royal Marsden Hospital NHS Foundation Trust)